These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38011563)

  • 21. Vortioxetine attenuates the effects of early-life stress on depression-like behaviors and monoamine transporters in female mice.
    Liu X; Sun YX; Zhang CC; Zhang XQ; Zhang Y; Wang T; Ma YN; Wang H; Su YA; Li JT; Si TM
    Neuropharmacology; 2021 Mar; 186():108468. PubMed ID: 33485943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex differences on the response to antidepressants and psychobiotics following early life stress in rats.
    Carlessi AS; Botelho MEM; Manosso LM; Borba LA; Maciel LR; Andrade NM; Martinello NS; Padilha APZ; Generoso CM; Bencke CV; de Moura AB; Lodetti BF; Collodel A; Joaquim L; Bonfante S; Biehl E; Generoso JS; Arent CO; Barichello T; Petronilho F; Quevedo J; Réus GZ
    Pharmacol Biochem Behav; 2022 Oct; 220():173468. PubMed ID: 36174752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
    Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM
    Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model.
    Yang C; Qu Y; Fujita Y; Ren Q; Ma M; Dong C; Hashimoto K
    Transl Psychiatry; 2017 Dec; 7(12):1294. PubMed ID: 29249803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antidepressant-like effects of escitalopram in mice require salt-inducible kinase 1 and CREB-regulated transcription co-activator 1 in the paraventricular nucleus of the hypothalamus.
    Shi TS; Li WY; Chen YM; Huang J; Guan W; Xu DW; Jiang B
    J Affect Disord; 2023 Oct; 338():228-238. PubMed ID: 37257779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model.
    Qu Y; Yang C; Ren Q; Ma M; Dong C; Hashimoto K
    Sci Rep; 2017 Nov; 7(1):15725. PubMed ID: 29147024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antidepressant effects of ketamine on depression-related phenotypes and dopamine dysfunction in rodent models of stress.
    Rincón-Cortés M; Grace AA
    Behav Brain Res; 2020 Feb; 379():112367. PubMed ID: 31739001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VGF and its C-terminal peptide TLQP-62 in ventromedial prefrontal cortex regulate depression-related behaviors and the response to ketamine.
    Jiang C; Lin WJ; Labonté B; Tamminga CA; Turecki G; Nestler EJ; Russo SJ; Salton SR
    Neuropsychopharmacology; 2019 Apr; 44(5):971-981. PubMed ID: 30504797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model.
    Zhang K; Toki H; Fujita Y; Ma M; Chang L; Qu Y; Harada S; Nemoto T; Mizuno-Yasuhira A; Yamaguchi JI; Chaki S; Hashimoto K
    Psychopharmacology (Berl); 2018 Nov; 235(11):3177-3185. PubMed ID: 30215218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imipramine treatment and resiliency exhibit similar chromatin regulation in the mouse nucleus accumbens in depression models.
    Wilkinson MB; Xiao G; Kumar A; LaPlant Q; Renthal W; Sikder D; Kodadek TJ; Nestler EJ
    J Neurosci; 2009 Jun; 29(24):7820-32. PubMed ID: 19535594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine.
    Chang L; Zhang K; Pu Y; Qu Y; Wang SM; Xiong Z; Ren Q; Dong C; Fujita Y; Hashimoto K
    Pharmacol Biochem Behav; 2019 Jun; 181():53-59. PubMed ID: 31034852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular adaptations of the blood-brain barrier promote stress resilience vs. depression.
    Dudek KA; Dion-Albert L; Lebel M; LeClair K; Labrecque S; Tuck E; Ferrer Perez C; Golden SA; Tamminga C; Turecki G; Mechawar N; Russo SJ; Menard C
    Proc Natl Acad Sci U S A; 2020 Feb; 117(6):3326-3336. PubMed ID: 31974313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of Antidepressant Effects of Low-Voltage-Sensitive T-Type Calcium Channel Blocker Ethosuximide in a Chronic Social Defeat Stress Model: Comparison with (R)-Ketamine.
    Tian Z; Dong C; Zhang K; Chang L; Hashimoto K
    Int J Neuropsychopharmacol; 2018 Nov; 21(11):1031-1036. PubMed ID: 30085247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice.
    Lindholm JS; Autio H; Vesa L; Antila H; Lindemann L; Hoener MC; Skolnick P; Rantamäki T; Castrén E
    Neuropharmacology; 2012 Jan; 62(1):391-7. PubMed ID: 21867718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine.
    Dong C; Zhang JC; Yao W; Ren Q; Ma M; Yang C; Chaki S; Hashimoto K
    Int J Neuropsychopharmacol; 2017 Mar; 20(3):228-236. PubMed ID: 27765808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidepressant, anxiolytic and procognitive effects of subacute and chronic ketamine in the chronic mild stress model of depression.
    Papp M; Gruca P; Lason-Tyburkiewicz M; Willner P
    Behav Pharmacol; 2017 Feb; 28(1):1-8. PubMed ID: 27759570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine.
    Yang C; Kobayashi S; Nakao K; Dong C; Han M; Qu Y; Ren Q; Zhang JC; Ma M; Toki H; Yamaguchi JI; Chaki S; Shirayama Y; Nakazawa K; Manabe T; Hashimoto K
    Biol Psychiatry; 2018 Oct; 84(8):591-600. PubMed ID: 29945718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluoxetine epigenetically alters the CaMKIIα promoter in nucleus accumbens to regulate ΔFosB binding and antidepressant effects.
    Robison AJ; Vialou V; Sun HS; Labonte B; Golden SA; Dias C; Turecki G; Tamminga C; Russo S; Mazei-Robison M; Nestler EJ
    Neuropsychopharmacology; 2014 Apr; 39(5):1178-86. PubMed ID: 24240473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of antidepressants in depression: A systematic review and meta-analysis.
    Yuan Z; Chen Z; Xue M; Zhang J; Leng L
    J Clin Neurosci; 2020 Oct; 80():169-181. PubMed ID: 33099342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring pharmacological options for adolescent depression: a preclinical evaluation with a sex perspective.
    Ledesma-Corvi S; Hernández-Hernández E; García-Fuster MJ
    Transl Psychiatry; 2022 Jun; 12(1):220. PubMed ID: 35650182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.